4.0 Article

The Methylation Status in the Chromosome 11p15.5 Region and Metabolic Disorders in Children with Syndromic and Nonsyndromic Intrauterine Growth Restriction

Journal

MOLECULAR SYNDROMOLOGY
Volume -, Issue -, Pages -

Publisher

KARGER
DOI: 10.1159/000518630

Keywords

11p15 hypomethylation; Intrauterine growth restriction; Short stature; Metabolic disorder; Silver-Russell syndrome; MLPA

Funding

  1. Istanbul University-Cerrahpasa [29,349]
  2. Turkish Pediatric Association

Ask authors/readers for more resources

The loss of methylation in the ICR1 of chromosome 11p15.5 is common in Silver-Russell syndrome patients, leading to typical craniofacial features. Maternal uniparental disomy was found in some SRS patients, and detection of typical facial findings is effective in the diagnosis of SRS. In contrast, methylation patterns were not impaired in nonsyndromic IUGR patients. Metabolic problems such as hypercalciuria, insulin resistance, and dyslipidemia were observed in both syndromic and nonsyndromic IUGR patients, emphasizing the importance of monitoring metabolic complications in patients with IUGR.
Loss of methylation (LoM) of the imprinting control region 1 (ICR1) in the chromosome 11p15.5 domain is detected in patients with Silver-Russell syndrome (SRS), characterized by asymmetric pre- and postnatal growth restriction, and typical craniofacial features. The patients with intrauterine growth restriction (IUGR) possess a high risk for adult metabolic problems. This study is aimed to investigate the methylation levels of the chromosome 11p15.5 region and metabolic problems in children with syndromic and nonsyndromic IUGR. Methylation analysis was performed for chromosome 11p15.5 in 49 patients (33 with suspected SRS and 16 nonsyndromic IUGR) with Netchine-Harbison clinical scoring (NHCS); uniparental disomy for chromosomes 6, 7, 14, and 20 was evaluated for those who were negative. LoM of ICR1 was detected in 14 of 33 suspected SRS patients with 3 or more criteria of NHCS, 5 had borderline LoM. Maternal uniparental disomy of the chromosomes 7 and 14 was found in 2 patients. The overall detection rate of SRS was 45.5%. While clinical findings were similar in patients with LoM and borderline LoM of ICR1, typical craniofacial findings were significantly less in the patients with normal methylation. Methylation patterns were not found to be impaired in the nonsyndromic IUGR group. Metabolic complications were evaluated in a total of 63 patients including 33 SRS-suspicious, 16 nonsyndromic IUGR, and 14 patients with 3M or SHORT syndrome. Increased rates of hypercalciuria, insulin resistance, and dyslipidemia were detected in patients with both syndromic and nonsyndromic IUGR. We would like to emphasize that detecting typical facial findings is effective in the diagnosis of SRS and paying attention to metabolic problems in the follow-up of patients with IUGR is recommended.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available